+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study



Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study



Journal of Medical Imaging and Radiation Oncology 54(5): 421-430



The purpose of this study was to assess the diagnostic accuracy of our early experience with contrast-enhanced ultrasound (CEUS) in the characterisation of focal liver lesions (FLLs) using histopathology, contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI) or other imaging follow-up as the standard of reference. Seventy-three patients with 82 FLLs who underwent liver CEUS from January 2006 to December 2008 were retrospectively reviewed. CEUS was performed with up to 4.8 mL of SonoVue® (Bracco, Milan, Italy) using a low mechanical index mode. The CEUS findings were compared with histopathology, or where histopathology was not available, clinical and imaging follow-up over at least 12 months was used as the standard of reference. Of the 82 FLLs, 50 were malignant and 32 were benign at final diagnosis. CEUS correctly identified 43 malignant FLLs, with final diagnosis confirmed by histopathology in 13 lesions and clinico-radiological follow-up in 30 lesions. Twenty-nine lesions were correctly identified as benign on CEUS, with all these lesions confirmed on clinico-radiological follow-up. CEUS demonstrated a sensitivity of 86.0% and a specificity of 90.6% in the characterisation of liver lesions as malignant, with an overall accuracy of 87.8% (P < 0.05). Our early experience has shown that CEUS can be accurate in differentiating malignant from benign FLLs and may become a useful first-line imaging tool where CT or MRI are not available or contra-indicated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052583421

Download citation: RISBibTeXText

PMID: 20958940

DOI: 10.1111/j.1754-9485.2010.02195.x


Related references

Clinical value of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions. Journal of Huazhong University of Science and Technology. Medical Sciences 27(6): 703-705, 2007

Comparative Diagnostic Accuracy of Contrast-Enhanced Ultrasound and Shear Wave Elastography in Differentiating Benign and Malignant Lesions: A Network Meta-Analysis. Frontiers in Oncology 9: 102, 2019

Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall in der Medizin 27(1): 40-48, 2006

Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver International 33(5): 739-755, 2013

Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. Journal of Clinical Ultrasound 38(1): 1-9, 2010

Contrast-Enhanced Ultrasound for the Characterization of Malignant Vs. Benign Focal Liver Lesions in a Prospective Multicenter Experience - Srumb Study. Ultrasound in Medicine & Biology 43: S48-S49, 2017

Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall in der Medizin 29(5): 499-505, 2009

Focal liver lesions in patients with malignant haematological disease: value of B-mode ultrasound in comparison to contrast-enhanced ultrasound--a retrospective study with N = 61 patients. Zeitschrift für Gastroenterologie 51(6): 558-567, 2014

The added value of contrast-enhanced ultrasound to conventional ultrasound in differentiating benign and malignant solid breast lesions: a systematic review and meta-analysis. Clinical Radiology 73(11): 936-943, 2018

Diagnostic accuracy and interobserver agreement of contrast-enhanced ultrasound in the evaluation of residual lesions after treatment for malignant lymphoma and testicular cancer: a retrospective pilot study in 52 patients. Leukemia and Lymphoma 59(11): 2622-2627, 2018

Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. European Journal of Radiology 81(12): 3890-3899, 2012

Contrast-Enhanced Ultrasound of Benign Focal Liver Lesions. Ultraschall in der Medizin 40(1): 12-29, 2019

Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound. Abdominal Imaging 37(4): 580-590, 2012

Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution. British Journal of Radiology 88(1049): 20140685, 2015

Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?. Investigative Radiology 42(8): 596-603, 2007